Resonance Speci.

Why is Resonance Specialities Ltd falling/rising?

As of 19-Jun, Resonance Specialities Ltd's stock is experiencing a decline of 1.0% today, continuing a two-day trend of losing value totaling 2.39%. Despite this short-term downturn, the stock has increased 36.40% year-to-date and shows strong long-term performance indicators.

As of 19-Jun, Resonance Specialities Ltd's stock price is currently falling, with a change of -1.4, representing a decrease of 1.0%. This decline is part of a broader trend, as the stock has been losing value for the last two days, resulting in a total drop of -2.39% during this period. Additionally, the stock opened with a loss of -2.72% today and reached an intraday low of Rs 136.05.<BR><BR>Despite the recent downturn, it is noteworthy that the stock has shown strong performance over longer periods, with a year-to-date increase of 36.40% compared to a decline of 9.88% in the Sensex. However, the current performance today indicates that it has underperformed its sector by -1.79%. <BR><BR>On a positive note, the stock is trading above its moving averages for 5 days, 20 days, 50 days, 100 days, and 200 days, suggesting a generally upward trend in the longer term. Furthermore, there has been a significant increase in investor participation, with delivery volume rising by 222.28% against the 5-day average, indicating growing interest in the stock despite its current price decline.

Which are the latest news on Resonance Speci.?

How big is Resonance Speci.?

As of 10th June, Resonance Specialities Ltd has a market capitalization of 158.00 Cr, with recent net sales of 90.24 Cr and a net profit of 10.40 Cr. Shareholder's funds are 64.02 Cr and total assets amount to 75.55 Cr as of March 2025.

As of 10th June, Resonance Specialities Ltd has a market capitalization of 158.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 90.24 Cr and a Net Profit of 10.40 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 64.02 Cr and Total Assets of 75.55 Cr.

Who are in the management team of Resonance Speci.?

The management team of Resonance Speci. includes Archana Yadav (Chairman), Prashant Godha (Non-Executive Director), Raj Kamal Prasad Verma (Independent Director), Ajay Patadia (Independent Director), Charchit Jain (Whole Time Director & CFO), Nilesh Jain (Non-Executive Director), and Vaibhavi Rajeshirke (Company Secretary & Compliance Officer).

The management team of Resonance Speci. includes the following individuals:<BR><BR>1. **Archana Yadav** - Chairman & Independent Director<BR>2. **Prashant Godha** - Non-Executive & Non-Independent Director<BR>3. **Raj Kamal Prasad Verma** - Independent Director<BR>4. **Ajay Patadia** - Independent Director<BR>5. **Charchit Jain** - Whole Time Director & CFO<BR>6. **Nilesh Jain** - Non-Executive Director<BR>7. **Vaibhavi Rajeshirke** - Company Secretary & Compliance Officer<BR><BR>If you need more specific information about any of these members or their roles, feel free to ask!

Who are the peers of the Resonance Speci.?

Resonance Speci.'s peers include Cochin Minerals, Dai-ichi Karkari, Jaysynth Orgo, Ishan Dyes, Polson, Chemcrux Enterp., Deep Polymers, and Ambani Orgochem. Notably, Ishan Dyes has the highest 1-year return at 31.54%, while Resonance Speci. has a return of 11.06%.

Peers: The peers of Resonance Speci. are Cochin Minerals, Dai-ichi Karkari, Jaysynth Orgo, Ishan Dyes, Polson, Chemcrux Enterp., Deep Polymers, and Ambani Orgochem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Cochin Minerals and Ambani Orgochem, while Average management risk is found at Jaysynth Orgo, Chemcrux Enterp., and Resonance Speci. Below Average management risk is present at Dai-ichi Karkari, Ishan Dyes, Polson, and Deep Polymers. Growth is Excellent at Jaysynth Orgo, while Below Average growth is noted at Cochin Minerals, Dai-ichi Karkari, Ishan Dyes, Polson, Chemcrux Enterp., and Ambani Orgochem. Average growth is seen at Deep Polymers. Excellent capital structure is attributed to Cochin Minerals and Resonance Speci., while Good capital structure is found at Dai-ichi Karkari and Chemcrux Enterp. Average capital structure is noted at Polson and Deep Polymers, with Below Average capital structure at Ishan Dyes and Ambani Orgochem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Ishan Dyes at 31.54%, while the lowest is Dai-ichi Karkari at -42.93%. Resonance Speci. has a 1-year return of 11.06%, which is higher than Dai-ichi Karkari but lower than Ishan Dyes. Additionally, Chemcrux Enterp., Deep Polymers, and Ambani Orgochem have negative six-month returns.

What does Resonance Speci. do?

Resonance Specialities Ltd manufactures and markets specialty chemicals, primarily Pyridine and its derivatives, and operates in the micro-cap market. As of March 2026, it reported net sales of 24 Cr and a net profit of 5 Cr, with a market cap of INR 158 Cr.

Overview:<BR>Resonance Specialities Ltd is a company engaged in the manufacturing and marketing of specialty chemicals, specifically Pyridine and its derivatives, and operates within the micro-cap market segment.<BR><BR>History:<BR>Incorporated in June 1989 as a Private Limited Company in Maharashtra, Resonance Specialities Ltd transitioned to a Public Limited Company in March 1990. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 24 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 5 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 158 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 15.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 0.76%<BR>- Debt-Equity: -0.14<BR>- Return on Equity: 14.20%<BR>- Price to Book: 2.07<BR><BR>Contact Details:<BR>Address: Plot No 54D Kandivli, Industrial Estate Kandivali W Mumbai Maharashtra : 400067<BR>Email: info@resonancesl.com<BR>Website: http://www.resonancesl.com

Are Resonance Specialities Ltd latest results good or bad?

Resonance Specialities Ltd's latest Q4 FY26 results are positive, showing a 50.33% increase in net profit to ₹4.60 crores and improved operating margins at 23.04%. However, the company faces long-term growth challenges, with a five-year annual sales growth rate of only 7.50%.

Resonance Specialities Ltd's latest results for Q4 FY26 can be characterized as positive overall. The company reported a net profit of ₹4.60 crores, which represents a significant 50.33% increase compared to the previous quarter. Additionally, revenue for the quarter reached ₹24.48 crores, marking a 6.62% sequential growth and a modest year-on-year increase of 1.16%.<BR><BR>One of the standout features of this quarter's performance is the operating margin, which improved to 23.04%, the highest level in seven quarters. This improvement reflects effective cost management and operational efficiency. The profit after tax (PAT) margin also saw a notable increase to 18.79%, up by 7.86 percentage points from the previous quarter.<BR><BR>However, while the quarterly results are strong, it's important to note that Resonance Specialities has faced challenges with long-term growth, evidenced by a five-year annual sales growth rate of only 7.50% and an operating profit growth rate of just 2.71%. This structural weakness may limit the company's ability to command premium valuations despite its recent operational improvements.<BR><BR>In summary, the latest results indicate a strong quarterly performance with impressive margins, but the company still grapples with long-term growth challenges that investors should consider.

Should I buy, sell or hold Resonance Specialities Ltd?

Is Resonance Speci. overvalued or undervalued?

As of December 4, 2025, Resonance Specialty Chemicals is considered overvalued with a PE ratio of 15.31 and an EV to EBITDA of 10.26, despite recent stock performance outpacing the Sensex, indicating its current market price does not reflect an attractive investment opportunity compared to peers like Solar Industries and Godrej Industries.

As of 4 December 2025, the valuation grade for Resonance Specialty Chemicals has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 15.31, an EV to EBITDA of 10.26, and a PEG ratio of 0.24, which suggests that while the company may have growth potential, its current price does not reflect an attractive investment opportunity.<BR><BR>In comparison to its peers, Resonance Specialty Chemicals stands out as overvalued, especially when compared to Solar Industries, which has a PE ratio of 88.66, and Godrej Industries, which is rated attractive with a PE of 35.01. The recent stock performance shows that Resonance has outperformed the Sensex over the past week and month, but its longer-term returns have lagged behind, reinforcing the notion that the current valuation may not be justified given the overall market context.

How has been the historical performance of Resonance Speci.?

Resonance Speci. has shown fluctuating financial performance, with net sales increasing to 77.81 Cr in Mar'25 from 55.30 Cr in Mar'24, while profit after tax rose to 6.57 Cr. However, the company faced cash flow challenges, reporting a net cash outflow of 1.00 Cr in Mar'25 despite overall growth.

Answer:<BR>The historical performance of Resonance Speci. shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Resonance Speci. has experienced varying net sales, with a notable increase to 77.81 Cr in Mar'25 from 55.30 Cr in Mar'24, although it had previously dipped to 58.81 Cr in Mar'23. The total operating income followed a similar pattern, reaching 77.81 Cr in Mar'25. The company's total expenditure, excluding depreciation, rose to 67.21 Cr in Mar'25 from 50.49 Cr in Mar'24, impacting the operating profit, which increased to 10.60 Cr in Mar'25 from 4.81 Cr in Mar'24. Profit before tax also saw an increase to 8.88 Cr in Mar'25, up from 3.96 Cr in Mar'24, while profit after tax rose to 6.57 Cr from 2.97 Cr in the same period. The earnings per share (EPS) improved significantly to 5.69 in Mar'25 from 2.57 in Mar'24. On the balance sheet, total assets increased to 75.55 Cr in Mar'25, up from 73.77 Cr in Mar'24, with total liabilities also rising to 75.55 Cr. The company reported a net cash outflow of 1.00 Cr in Mar'25, indicating challenges in cash flow management despite the growth in sales and profits.

Who are the top shareholders of the Resonance Speci.?

The top shareholders of Resonance Speci. are Makers Laboratories Limited with 45.48%, followed by Avignon Exim Private Limited at 2.22%. Individual investors own 33.22%, and there is one foreign institutional investor with a 0.03% stake, while mutual funds do not hold any shares.

The top shareholders of Resonance Speci. include Makers Laboratories Limited, which holds the largest stake at 45.48%. The highest public shareholder is Avignon Exim Private Limited, with a holding of 2.22%. Additionally, individual investors collectively own 33.22% of the company. There are no pledged promoter holdings, and the company has one foreign institutional investor (FII) holding a small stake of 0.03%. Mutual funds do not hold any shares in the company.

What is the technical trend for Resonance Speci.?

As of June 6, 2025, Resonance Speci. shows a mildly bullish trend supported by positive weekly and monthly MACD and Bollinger Bands, despite some short-term weakness indicated by daily moving averages.

As of 6 June 2025, the technical trend for Resonance Speci. has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive outlook, while the monthly MACD is mildly bullish. Both the weekly and monthly Bollinger Bands are bullish, indicating upward momentum. The Dow Theory also reflects a mildly bullish stance on both weekly and monthly time frames. However, the daily moving averages are mildly bearish, which suggests some short-term weakness. Overall, the current technical stance is mildly bullish, driven primarily by the positive signals from MACD and Bollinger Bands, despite some mixed signals from moving averages.

When is the next results date for Resonance Speci.?

No Upcoming Board Meetings

Has Resonance Speci. declared dividend?

Yes, Resonance Specialities Ltd has declared a 10% dividend, amounting to ₹1 per share, with an ex-date of August 1, 2023. Despite this, the dividend yield is 0%, but the company has shown strong price performance with a total return of 184.54% over the last 5 years.

Resonance Specialities Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 01 Aug 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 16.05%, with no dividend return, resulting in a total return of 16.05%.<BR><BR>Over the past year, the price return was 16.28%, with no dividend return, leading to a total return of 16.28%.<BR><BR>In the 2-year period, the price return was 48.88%, with a dividend return of 1.17%, culminating in a total return of 50.05%.<BR><BR>For the 3-year period, the price return was -20.53%, with a dividend return of 1.39%, resulting in a total return of -19.14%.<BR><BR>In the 4-year timeframe, the price return was -24.97%, with a dividend return of 2.05%, leading to a total return of -22.92%.<BR><BR>Finally, over the last 5 years, the price return was 177.78%, with a dividend return of 6.76%, resulting in a total return of 184.54%.<BR><BR>Overall, while Resonance Specialities Ltd has declared a dividend, the dividend yield remains at 0%. The total returns show a positive trend over the last 5 years, indicating strong price performance despite fluctuations in dividend returns across different periods.